Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2001-09-14
2010-12-21
Andres, Janet L. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S341000
Reexamination Certificate
active
07855297
ABSTRACT:
The present invention relates to an amide derivative of the formula (1), having a C5a receptor antagonistic actionwherein each symbol is as defined in the specification.The above-mentioned amide derivative, an optically active form thereof and a pharmaceutically acceptable salt thereof are promising as an agent for the treatment or prophylaxis of diseases or syndromes caused by inflammation caused by C5a [e.g., autoimmune diseases such as rheumatism, systemic lupus erythematosus and the like, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergic diseases such as asthma and the like, atherosclerosis, cardiac infarction, brain infarction, psoriasis, Alzheimer's disease and serious organ injury (e.g., pneumonia, nephritis, hepatitis and pancreatitis and the like) due to activation of leukocytes caused by ischemia reperfusion, trauma, burn, surgical invasion and the like]. Moreover, they are useful as a therapeutic or prophylactic agent for the infectious diseases caused by bacteria and virus that invade via a C5a receptor.
REFERENCES:
patent: 5491152 (1996-02-01), Wilde et al.
patent: 2008/0194640 (2008-08-01), Nakamura et al.
patent: 181136 (1986-05-01), None
patent: 0181136 (1986-10-01), None
patent: 0 512 570 (1992-11-01), None
patent: 0978279 (1999-07-01), None
patent: 978279 (2000-02-01), None
patent: 5-294960 (1993-11-01), None
patent: 10-182648 (1998-07-01), None
patent: 94/07815 (1994-04-01), None
patent: 94/27971 (1994-12-01), None
patent: 99/00406 (1999-01-01), None
Hcaplus 133:104964.
Price et. al., “Some Naphthaiene Analogs of Desoxycorticosterone”, Journal of the American Chemical Society, 69, 2261-4, 1947.
J. Ember et al., “Complement factors and their receptors”, Immunopharmacology, vol. 38, pp. 3-15, 1997.
C. Gerard et al., “C5a Anaphylatoxin and its seven transmembrane-segement receptor”, Annu. Rev. Immunol., Vo. 12, pp. 775-808, 1999.
A. Wong et al., “Development of C5a receptor antagonists”, IDrugs, vol. 2, No. 7, pp. 686-693, 1999.
T. Pellas et al., “C5a Receptor Antagonists”, Current Pharmaceutical Design, vol. 5, pp. 737-755 1999.
T. J. Lanza et al., “Substituted 4,6-Diaminoquinolines as Inhibitors of C5a Receptor Binding”, J. Med. Chem., vol. 35, pp. 252-258, 1992.
Ishibuchi Seigo
Itoh Katsuhiko
Kamahori Takao
Naka Yoichi
Nakamura Mitsuharu
Andres Janet L.
Mitsubishi Tanabe Pharma Corporation
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Robinson Binta
LandOfFree
Amide derivatives and medicinal use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amide derivatives and medicinal use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide derivatives and medicinal use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4228551